Загрузка...
Gonadotropin-releasing hormone agonist use in men without a cancer registry diagnosis of prostate cancer
BACKGROUND: Use of gonadotropin-releasing hormone (GnRH) agonists has become popular for virtually all stages of prostate cancer. We hypothesized that some men receive these agents after only a limited work-up for their cancer. Such cases may be missed by tumor registries, leading to underestimates...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2483971/ https://ncbi.nlm.nih.gov/pubmed/18620606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6963-8-146 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|